Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001708138-21-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-17 | 2021-08-13+ | REGN | YANCOPOULOS GEORGE | Pres, Chief Scientific, Dir | S - Sale | $625.29 | -50.0K | 889.8K | -5% | -$31.26M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | S | D | 2,302 | $626.10 | 887,483 | D | — | — | (F3) Represents volume-weighted average price of sales of 2,302 shares of Company stock on August 16, 2021 at prices ranging from $626.00 to $626.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-08-13 | S | D | 773 | $625.00 | 936,710 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-16 | S | D | 46,925 | $625.25 | 889,785 | D | — | — | (F2) Represents volume-weighted average price of sales of 46,925 shares of Company stock on August 16, 2021 at prices ranging from $625.00 to $625.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price. |